Cargando…

Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network

The aim of this study was to investigate the effect and possible mechanism of Astragaloside IV (AS-IV) on retarding the progression of diabetic nephropathy (DN) in a type 2 diabetic animal model, db/db mice. Eight-week-old male db/db diabetic mice and their nondiabetic littermate control db/m mice w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xinhui, Wang, Wenjing, Song, Gaofeng, Wei, Xian, Zeng, Youjia, Han, Pengxun, Wang, Dongtao, Shao, Mumin, Wu, Juan, Sun, Huili, Xiong, Guoliang, Li, Shunmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540580/ https://www.ncbi.nlm.nih.gov/pubmed/28767702 http://dx.doi.org/10.1371/journal.pone.0182558

Ejemplares similares

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice
por: Song, Gaofeng, et al.
Publicado: (2018)

Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ‐Induced Diabetic Mice
por: Wang, Dongtao, et al.
Publicado: (2018)

Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in mice
por: Han, Pengxun, et al.
Publicado: (2021)

The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy
por: Li, Ziyu, et al.
Publicado: (2022)

Artemether ameliorates adriamycin induced cardiac atrophy in mice
por: Weng, Wenci, et al.
Publicado: (2023)

Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy
por: Cai, Yuchun, et al.
Publicado: (2021)

Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity
por: Luo, Zhixiao, et al.
Publicado: (2021)

Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
por: Wang, Zeng Si, et al.
Publicado: (2015)

Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation
por: Feng, Hui, et al.
Publicado: (2021)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
por: Sun, Chuang, et al.
Publicado: (2021)

A Chinese herbal formula, Jian-Pi-Yi-Shen decoction, improves muscle atrophy via regulating mitochondrial quality control process in 5/6 nephrectomised rats
por: Wang, Dongtao, et al.
Publicado: (2017)

Retraction Note: A Chinese herbal formula, Jian-Pi-Yi-Shen decoction, improves muscle atrophy via regulating mitochondrial quality control process in 5/6 nephrectomised rats
por: Wang, Dongtao, et al.
Publicado: (2021)

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2018)

Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
por: Zhang, Yudi, et al.
Publicado: (2020)

Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy
por: Meng, LQ, et al.
Publicado: (2011)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
por: Zhao, Zhen Xiong, et al.
Publicado: (2022)

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function
por: Zhang, Wen, et al.
Publicado: (2022)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Astragaloside IV ameliorates allergic inflammation by inhibiting key initiating factors in the initial stage of sensitization
por: Bao, Kai-fan, et al.
Publicado: (2016)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB
por: QIU, LEI, et al.
Publicado: (2015)

Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC‐1α to reduce apoptosis in vitro and in vivo
por: Xie, Mingxia, et al.
Publicado: (2023)

Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites
por: Du, Xu-Qin, et al.
Publicado: (2022)

Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload
por: Xie, Dongyu, et al.
Publicado: (2019)

Ameliorating the Effect of Astragaloside IV on Learning and Memory Deficit after Chronic Cerebral Hypoperfusion in Rats
por: Kim, Sooyong, et al.
Publicado: (2015)

Astragaloside IV Attenuated 3,4-Benzopyrene-Induced Abdominal Aortic Aneurysm by Ameliorating Macrophage-Mediated Inflammation
por: Wang, Jiaoni, et al.
Publicado: (2018)

Astragaloside II Ameliorated Podocyte Injury and Mitochondrial Dysfunction in Streptozotocin-Induced Diabetic Rats
por: Su, Jun, et al.
Publicado: (2021)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling
por: Tong, Jiahuan, et al.
Publicado: (2021)

Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
por: Fan, Yuyan, et al.
Publicado: (2019)

Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3/caspase-1 signaling pathway
por: Wu, Shan, et al.
Publicado: (2023)

Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
por: Wang, Hong, et al.
Publicado: (2020)

Astragaloside IV Reduces OxLDL-Induced BNP Overexpression by Regulating HDAC
por: Zhang, Wenting, et al.
Publicado: (2021)

Jian-Pi-Yi-Shen formula enhances perindopril inhibition of chronic kidney disease progression by activation of SIRT3, modulation of mitochondrial dynamics, and antioxidant effects
por: Liu, Xinhui, et al.
Publicado: (2021)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
por: Tan, Junlan, et al.
Publicado: (2023)

Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 Signaling Pathway
por: Jin, Hualiang, et al.
Publicado: (2017)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n5dqt43i22nirkk8lainbu16ki